Short cylindrical glass bottle (b) inside a cardboard box (a); vial is stopped with a rubber stopper and sealed with a metal cap; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper label on front and sides and is full of liquid.
Short cylindrical glass bottle (b) inside a cardboard box (a); vial is stopped with a rubber stopper and sealed with a metal cap; a plastic cap covers the metal cap such that when it is pulled off it breaks the seal on the metal cap; vial has a paper label on front and sides and is full of liquid.
Number Of Parts
2
Part Names
a - box - Size: Length 5.3 cm x Width 2.9 cm x Depth 2.9 cm
(a) Front: "5 ML. Bio. 1508 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1972-73 season. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injec- // tions of 0.5 ml. each, given at least two months // apart. See package insert. // [dosage repeated in French] // Prepared from formalin stabilized, zonally cen- // trifuged antigens, ether-extracted from virus // propagated in the extraembryonic fluid of the // chick embryo. // U.S. Patent No. 3,105,012 // Polysorbate 80, U.S.P., added during // manufacture."; back: "5 ML. Bio, 1508 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C // Contains 700 CCA units of A/Aichi/2/68/X-31 (H3N2) // strain (Hong Kong Variant) and 300 CCA units of // B/Massachusetts/1/71 strain in each 0.5-ml. dose. // Stock 4-1508-1-70 // PARKE-DAVIS"; bottom: "Contains 0.01% thimerosal (mercury derivative) // as a preservative. // U.S. Licence No. 1. // Canadian Licence No. 1. // Store at temperature between 2° and 8° C. (36° and 46° F.). // FREEZING DESTROYS POTENCY // SHAKE WELL BEFORE USING // Parke, Davis & Company // Detroit, Michigan 48232 // U.S.A. // XG YBY "; right side: "5 ML. Bio. 1508 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot // Dec. 10, 1973 // 900259C"; left side: "5 ML. Bio. 1508 // FLUOGEN // Parke, Davis & Co. // Stock 4-1508-1-70"; (b) front: "C // 5 ML. Bio. 1508 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains 700 CCA units of A/Aichi/2/68/X-31 (H3N2) // strain (Hong Kong Variant) and 300 CCA units of // B/Massachusetts/1/71 strain in each 0.5-ml. dose. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE–Two // intramuscular injections of 0.5 // ml. each, given at least two // months apart. See package // insert. // Standardized according to the // U.S. Public Health Service // requirements for the 1972-73 season. // U.S. Lic. No. 1. // Canadian Lic. No. 1 // Exp. Date and Lot [printed] // Dec. 10, 1973 // 900259C [stamped]"; bottom: "W // 103 [embossed]"; top: "FLIP // OFF [embossed]"
Permanent Location
Storage Room 0010
0010-A3-7 Row G
Condition Remarks
Box yellowing, dirty, scuffed, torn in two places on the bottom; no apparent problems with vial
Copy Type
Original
Research Facts
This is a vaccine against the influenza virus and is administered intramuscular with a hypodermic syringe.